Epidarex Capital: Valuation, Funding & Investors
Epidarex Capital is a transatlantic life science venture firm that creates and invests in early-stage therapeutics and medical device companies. The firm focuses on company creation and early-stage investing across the UK and US, partnering with researchers and entrepreneurs to build IP-rich life science businesses and scale innovations from research institutions.
Leadership & Board
- Current Number of Employees
- 17
- Current LinkedIn Followers
- 4,920
Latest Estimated Valuation
- Total Amount Raised
- $145M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $145M
- Latest Funding Round
- Investment
Employee Trend
Epidarex Capital had 17 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
17Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Epidarex Capital had 4,920 followers as of October 26, 2026. The number of followers increased by 21 (0.43%) week-over-week.
4,920Latest Followers Count
21(0.43%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 27, 2026 | Investment | $145.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| British Business Bank | Investment |
| Leading family offices | Investment |
| Scottish National Investment Bank | Investment |
| Strathclyde Pension Fund | Investment |
| corporates | Investment |
| other international investors | Investment |
Similar Companies
A snapshot of private companies similar to Epidarex Capital, helping you discover and navigate related company profiles.
